Marshall Wace, LLP Quanterix Corp Transaction History

Marshall Wace, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.26 - $23.78 $316,308 - $613,524	25,800 New	25,800 $340,000
Q4 2022 Feb 14, 2023	SELL	$8.75 - $14.02 $1.01 Million - $1.61 Million	-115,116 Reduced 54.43%	96,369 $1.33 Million
Q3 2022 Nov 14, 2022	SELL	$7.46 - $19.28 $6.44 Million - $16.6 Million	-862,896 Reduced 80.32%	211,485 $2.33 Million
Q2 2022 Aug 15, 2022	SELL	$15.06 - $30.65 $6.22 Million - $12.7 Million	-413,221 Reduced 27.78%	1,074,381 $17.4 Million
Q1 2022 May 16, 2022	SELL	$23.26 - $42.41 $2.04 Million - $3.72 Million	-87,780 Reduced 5.57%	1,487,602 $43.4 Million
Q4 2021 Feb 14, 2022	BUY	$37.54 - $57.51 $727,600 - $1.11 Million	19,382 Added 1.25%	1,575,382 $66.8 Million
Q3 2021 Nov 15, 2021	BUY	$45.91 - $59.67 $6.49 Million - $8.44 Million	141,431 Added 10.0%	1,556,000 $77.5 Million
Q2 2021 Aug 13, 2021	BUY	$43.3 - $67.17 $12.9 Million - $20 Million	297,476 Added 26.63%	1,414,569 $83 Million
Q1 2021 May 17, 2021	BUY	$44.11 - $90.64 $1.76 Million - $3.61 Million	39,873 Added 3.7%	1,117,093 $65.3 Million
Q4 2020 Feb 16, 2021	BUY	$33.89 - $49.88 $32 Million - $47.1 Million	945,085 Added 715.24%	1,077,220 $50.1 Million
Q3 2020 Nov 16, 2020	BUY	$26.91 - $37.47 $2.5 Million - $3.48 Million	92,744 Added 235.44%	132,135 $4.46 Million
Q2 2020 Aug 13, 2020	BUY	$19.21 - $28.53 $756,701 - $1.12 Million	39,391 New	39,391 $1.08 Million

157

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $348M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.